The Open University
Cellular TRIM33 ubiquitin ligase restricts HIV-1 infection by targeting viral integrase
Abstract
dc:description.abstractHuman Immunodeficiency virus-1 Integrase (HIV-1IN) is essential for the virus life cycle since it catalyzes the integration of the viral genome into the host cell chromosomes. Integrated viral genome provides a favorable niche for gene expression and can become latent and further unrecognizable by antiviral drugs. During an early phase of infection, the host ubiquitin-proteasome machinery senses the IN protein and selectively degrades it in order to block the viral cDNA integration. HIV-1 is an obligatory parasite, which uses diverse host cellular machineries and host factors to protect or hide IN from host ubiquitin-proteasome, as well as the host enzymes that positively regulate IN stability. It is well established that the host ubiquitin-proteasome plays an inhibitory role in the early stage of replication by selectively degrading incoming viral proteins (including IN); however, the cellular factors that are responsible for IN ubiquitin-mediated degradation remain still undefined. Study of the cellular factors that mediate IN degradation during the early stages of viral replication might be a valuable tool in discovering novel targets for AIDS drug development. In this thesis, we describe and characterize a cellular factor, TRIM33, which selectively targets IN for ubiquitin-proteasome mediated degradation. TRIM33 was identified as IN destabilizing factor in high throughput screening, based on high-content fluorescent microscopy, using a library of ~600 siRNAs against factors in the ubiquitin-conjugation pathway. It belongs to a large family of TRIM proteins, which harbor antiviral activities against different viruses. TRIM33 has also been shown to regulate the stability of cellular proteins in an ubiquitin-proteasome dependent manner. We show here that TRIM33 acts as a novel IN ubiquitin E3-ligase, and that its RING domain is essential for ubiquitin E3 ligase activity. It interacts physically with IN inside the nucleus, with the C-terminal domain of IN and the TRIM domain of the TRIM33 being involved in IN-TRIM33 interaction. The silencing of TRIM33 protein increased HIV-1 integration in primary CD4+ T cells and the lymphoid SupT1 cell line. Most interestingly, knockdown of the TRIM33 reverted the phenotype of the mutant virus (IN S57A) carrying a destabilizing point mutation in the IN protein. In conclusion, the newly discovered cellular TRIM33 is a novel restriction factor for HIV-1 infection, which acts by targeting viral integrase protein for degradation through the ubiquitin-proteasome pathway
Degree
thesis:*- Name dc:type.qualificationname
- phd
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- The Open University
- Year dc:date.issued
- 2015
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Ali, Hashim
Rights
- Language dc:language
- en